Diuril Injectable Drug Recalled Due to Manufacturing Quality Deviations
Akorn, Inc. is recalling all lots of Diuril (chlorothiazide sodium) Injection, 500mg/vial, distributed nationwide, due to manufacturing deviations. The manufacturer went out of business and was unable to complete required stability studies.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for an injectable drug where the manufacturer was unable to complete required stability studies due to business closure. No illnesses or injuries have been reported. The hazard—unverified product stability and quality—is theoretical, making a High severity appropriate.
Plain-English summary
Diuril (chlorothiazide sodium) Injection, 500mg/vial, is being recalled by Akorn, Inc. The recall affects all lots of the product distributed nationwide in the United States and Puerto Rico.
The recall is due to Current Good Manufacturing Practice (CGMP) deviations. The manufacturer went out of business and could not complete the stability studies required to verify the product's safety and effectiveness throughout its shelf life. Without these studies, the product cannot be confirmed to meet FDA standards for quality and safety.
Patients and healthcare providers who have received or used this medication should consult with their healthcare provider about next steps. Patients should not use any remaining doses of this product. Unused product should be returned to the dispensing pharmacy or appropriate disposal facility.
The recalled product
- Product
- Diuril (chlorothiazide sodium) Injection, 500mg/vial, Single-Dose Vial, Rx Only, Distributed by: Akorn Operating Company, LLC., Gurnee, IL 60031. ALL NDCs
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Injectable
- Hazard
- manufacturing-defect
- stability-unverified
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27